Skip to main content

Table 2 The number of studies and patient samples included for different interventions

From: A network meta-analysis evaluating the efficacy and safety of adjuvant therapy after nephrectomy in renal cell carcinoma

Treatment

Study

Sample size

nivolumab + ipilimumab

1

405

IL2 + IFN + 5FU

2

289

atezolizumab

1

390

pazopanib

2

1538

pembrolizumab

2

992

sorafenib

5

2349

sunitinib

3

1314

girentuximab

1

433

tegafur + uracil

1

33

axitinib

1

363

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us